STATUTORY COMMUNICATIONS 2024 - 2025
Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited
Update on Transfer and assignment of Pfizer’s unexpired leasehold rights in MIDC Land to Zoetis Pharmaceutical Research Private Limited
Intimation regarding completion of term of Independent Directorship of Mr. Sunil Lalbhai
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- GST Order
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- GST Order
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- GST Order
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- GST Order
Intimation regarding change in Senior Management Personnel of the Company
Notice for the Board Meeting – January 31, 2025
Notice of closure for Trading Window - December 31, 2024
Intimation regarding appointment of Senior Management Personnel of the Company.
Intimation regarding completion of term of Independent Directorship of Mr. Pradip Shah and Mr. Uday Khanna.
Intimation regarding change in Senior Management Personnel of the Company
Disclosure on Related Party Transactions as on September 30, 2024
Pfizer Limited – Notice for the Board Meeting – October 28, 2024
Pfizer Limited – Notice of closure for Trading Window - September 30, 2024
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
E-voting results for the 73rd Annual General Meeting held on August 28, 2024
Proceedings of the 73rd Annual General Meeting
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Corrigendum to Notice of the 73rd Annual General Meeting – Intimation of revised record date
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation regarding change in Board of Directors
Pfizer Limited – Notice for the Board Meeting – July 29, 2024
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation regarding change in Senior Management Personnel of the Company
Pfizer Limited – Notice of closure for Trading Window – June 30, 2024
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Contact details of the authorized Key Managerial Personnel for determining materiality of an event or information
Disclosure on Related Party Transactions as on March 31, 2024
Pfizer Limited – Notice for the Board Meeting – May 17, 2024
Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation regarding appointment of Cost Auditors
Pfizer Limited – Results of the Postal Ballot E-voting – April 2, 2024